[Asia Economy Reporter Hwang Yoon-joo] BioPlus announced on the 18th that it has completed the acquisition of a 45,837㎡ site within the Seongbon Industrial Complex in Eumseong-gun, Chungcheongbuk-do.
BioPlus explained that this is "to secure a business (production) site for business expansion in the field of biological preparations [botulinum toxin, obesity treatment (GLP-1 injection), virus treatment] and for the expansion of the hyaluronic acid-based biomaterial application product line."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
